DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Noh WC, Lee JW, Nam SJ. et al.
Role of adding ovarian function suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or resume menstruation after chemotherapy: The ASTRRA study.
J Clin Oncol 2018;
36 (Suppl.) Abstr. 502
We do not assume any responsibility for the contents of the web pages of other providers.